Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00075) | |||||
---|---|---|---|---|---|
Name |
Bosutinib
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Bosutinib; 380843-75-4; SKI-606; Bosutinib (SKI-606); SKI 606; SKI606; BOSULIF; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile; 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile; UNII-5018V4AEZ0; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile; BOSUTINIB ISOMER 1; CHEMBL288441; 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile; 4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile; CHEBI:39112; 5018V4AEZ0; SKI-606); MFCD07367846; SK-606; Bosutinib (USAN); Bosutinib [USAN:INN]; NCGC00241107-01; WAY-173606; Bosutinib,SKI-606; PubChem22404; Bosutinib (SKI606); Bosutinib(SKI-606); PF-5208763; Bosutinib - SKI-606; EC 700-455-1; cc-357; MLS006011212; SCHEMBL158390; BDBM4552; GTPL5710; QCR-26; Bosutinib, >=98% (HPLC); DTXSID10861568; EX-A391; SYN1025; BCPP000318; HMS2043A22; HMS3244A03; HMS3244A04; HMS3244B03; HMS3651C03; HMS3672K11; HMS3743E09; 2-PYRIDIN-2-YLETHYLACETATE; K00615a; AOB87309; BCP01782; ABP000235; NSC765694; NSC799367; SK 606; ZINC22448983; AKOS015902521; AC-2413; BCP9000446; CCG-208129; CS-0118; DB06616; NSC-765694; NSC-799367; PB30881; NCGC00241107-03; NCGC00241107-05; AK544289; AS-11064; HY-10158; SMR002530350; AB0008633; FT-0656231; SKI606; SKI 606; SK-I606; SW220197-1; A25014; D03252; Q-4427; AB01565836_03; 843B754; Q894611; SR-01000941572; J-519931; Q-200745; SR-01000941572-1; BRD-K99964838-001-01-0; BRD-K99964838-001-06-9; 3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-; 4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile; SKI-606;4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-quinoline-3-carbonitrile
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Chronic myelogenous leukaemia | ICD-11: 2A20 | [1] | ||
PubChem CID | |||||
Formula |
C26H29Cl2N5O3
|
||||
Canonical SMILES |
CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
|
||||
InChI |
1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)
|
||||
InChIKey |
UBPYILGKFZZVDX-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5328940"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 530.4 | Topological Polar Surface Area | 82.9 | |
XlogP | 5.4 | Complexity | 734 | ||
Heavy Atom Count | 36 | Rotatable Bond Count | 9 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Bosutinib Monohydrate eq 400mg base tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Microcrystalline Cellulose; Croscarmellose Sodium; Poloxamer; Povidone; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Iron Oxide Yellow; Iron Oxide Red
|
|||||
Dosage Form | Tablet | |||||
Company | Pf Prism Cv | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Bosutinib Monohydrate eq 500mg base tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Microcrystalline Cellulose; Croscarmellose Sodium; Poloxamer; Povidone; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Iron Oxide Red
|
|||||
Dosage Form | Tablet | |||||
Company | Pf Prism Cv | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Bosutinib Monohydrate eq 100mg base tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Microcrystalline Cellulose; Croscarmellose Sodium; Poloxamer; Povidone; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Iron Oxide Yellow
|
|||||
Dosage Form | Tablet | |||||
Company | Pf Prism Cv | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Bosutinib 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Croscarmellose sodium; Poloxamer 188; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Povidone k25
|
|||||
Dosage Form | Oral Tablet | |||||
Company | U.S. Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [2] | |||
Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Croscarmellose sodium; Poloxamer 188; Polyethylene glycol 3350; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Povidone k25
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Pfizer Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Bosutinib 400 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Croscarmellose sodium; Poloxamer 188; Polyethylene glycol 3350; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Povidone k25
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Pfizer Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Bosutinib 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Croscarmellose sodium; Poloxamer 188; Polyethylene glycol 3350; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Povidone k25
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Pfizer Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.